Goyal RK, Zhang J, Dhuliawala S, Slug-O'Callaghan M, Kaufman PA. Real-world treatment patterns and clinical outcomes in patients treated with eribulin after prior Immunotherapy (IO) or Antibody-Drug Conjugate (ADC) for metastatic breast cancer. Poster presented at the 39th Annual Miami Breast Cancer Conference; March 3, 2022. Miami Beach, FL.

Abstract not available at this time.

Share on: